StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Tibet Cheezheng Tibetan Medicine Co., Ltd.
Shenzhen Stock Exchange:002287.SZ
Sector
Location
Market Cap
USD 1.64 B
Share Price
USD 3.14
Avg Daily Volume
3,301,088
Change (1 day)
0.38%
Change (1 year)
17.96%
Change (YTD)
6.98%
Tibet Cheezheng Tibetan Medicine Co., Ltd. Accounts Payable for the year ending December 31, 2024: USD 32.25 M
Tibet Cheezheng Tibetan Medicine Co., Ltd. Accounts Payable is USD 32.25 M for the year ending December 31, 2024, a -14.01% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
-
Tibet Cheezheng Tibetan Medicine Co., Ltd. Accounts Payable for the year ending December 31, 2023 was USD 37.50 M, a 307.32% change year over year.
-
Tibet Cheezheng Tibetan Medicine Co., Ltd. Accounts Payable for the year ending December 31, 2022 was USD 9.21 M, a -68.21% change year over year.
-
Tibet Cheezheng Tibetan Medicine Co., Ltd. Accounts Payable for the year ending December 31, 2021 was USD 28.96 M, a 262.02% change year over year.
-
Tibet Cheezheng Tibetan Medicine Co., Ltd. Accounts Payable for the year ending December 31, 2020 was USD 8.00 M, a 175.87% change year over year.
Competitors
GE HealthCare Technologies Inc.
USD 74.45
GEHC
-0.68
-0.91%
Laboratory Corporation of America Holdings
USD 249.80
LH
+0.18
0.07%
Torrent Pharmaceuticals Limited
USD 39.36
TORNTPHARM.NS
-0.23
-0.58%
Ascendis Pharma A/S
USD 174.88
ASND
-0.08
-0.04%
Regencell Bioscience Holdings Limited
USD 14.68
RGC
-0.07
-0.47%
Laurus Labs Limited
USD 9.67
LAURUSLABS.NS
+0.09
0.95%
ADMA Biologics, Inc.
USD 18.68
ADMA
+0.17
0.92%
Ipca Laboratories Limited
USD 17.06
IPCALAB.NS
+0.13
0.74%
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
USD 2.09
002603.SZ
+0.01
0.25%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.67
600566.SS
+0.01
0.28%
Pfizer Limited
USD 63.49
PFIZER.NS
+0.57
0.90%
BGI Genomics Co., Ltd.
USD 6.89
300676.SZ
-0.03
-0.40%
Eris Lifesciences Limited
USD 20.29
ERIS.NS
-0.02
-0.11%
Liaoning Cheng Da Co., Ltd.
USD 1.65
600739.SS
+0.02
1.26%
Hybio Pharmaceutical Co., Ltd.
USD 2.63
300199.SZ
+0.05
2.03%
Vimian Group AB (publ)
USD 4.38
VIMIAN.ST
+0.03
0.71%
NovoCure Limited
USD 17.42
NVCR
-0.18
-1.02%
Harmony Biosciences Holdings, Inc.
USD 34.71
HRMY
+0.71
2.09%
Zhejiang Jingxin Pharmaceutical Co., Ltd.
USD 2.16
002020.SZ
-0.01
-0.47%
Adaptive Biotechnologies Corporation
USD 11.55
ADPT
-0.27
-2.28%
Key Data
| Date | Accounts Payable | Short-Term Debt | Long-Term Debt | Total Liabilities |
|---|
Competitors
GE HealthCare Technologies Inc.
USD 74.45
GEHC
-0.68
-0.91%
Laboratory Corporation of America Holdings
USD 249.80
LH
+0.18
0.07%
Torrent Pharmaceuticals Limited
USD 39.36
TORNTPHARM.NS
-0.23
-0.58%
Ascendis Pharma A/S
USD 174.88
ASND
-0.08
-0.04%
Regencell Bioscience Holdings Limited
USD 14.68
RGC
-0.07
-0.47%
Laurus Labs Limited
USD 9.67
LAURUSLABS.NS
+0.09
0.95%
ADMA Biologics, Inc.
USD 18.68
ADMA
+0.17
0.92%
Ipca Laboratories Limited
USD 17.06
IPCALAB.NS
+0.13
0.74%
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
USD 2.09
002603.SZ
+0.01
0.25%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.67
600566.SS
+0.01
0.28%
Pfizer Limited
USD 63.49
PFIZER.NS
+0.57
0.90%
BGI Genomics Co., Ltd.
USD 6.89
300676.SZ
-0.03
-0.40%
Eris Lifesciences Limited
USD 20.29
ERIS.NS
-0.02
-0.11%
Liaoning Cheng Da Co., Ltd.
USD 1.65
600739.SS
+0.02
1.26%
Hybio Pharmaceutical Co., Ltd.
USD 2.63
300199.SZ
+0.05
2.03%
Vimian Group AB (publ)
USD 4.38
VIMIAN.ST
+0.03
0.71%
NovoCure Limited
USD 17.42
NVCR
-0.18
-1.02%
Harmony Biosciences Holdings, Inc.
USD 34.71
HRMY
+0.71
2.09%
Zhejiang Jingxin Pharmaceutical Co., Ltd.
USD 2.16
002020.SZ
-0.01
-0.47%
Adaptive Biotechnologies Corporation
USD 11.55
ADPT
-0.27
-2.28%